Skip Navigation

Cardiovascular Research 2000 45(2):418-427; doi:10.1016/S0008-6363(99)00343-0
© 2000 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bouchard, J.-F.
Right arrow Articles by Lamontagne, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bouchard, J.-F.
Right arrow Articles by Lamontagne, D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2000, European Society of Cardiology

Participation of prostaglandin E2 in the endothelial protective effect of ischaemic preconditioning in isolated rat heart

Jean-François Bouchard, Jérôme Chouinard and Daniel Lamontagne*

Faculty of Pharmacy, University of Montreal, P.O. Box 6128, Station Centre-ville, Montreal, Quebec, Canada H3C 3J7

* Corresponding author. Tel.: +1-514-343-5909; fax: +1-514-343-2102 Daniel.Lamontagne{at}umontreal.ca

Objective: To assess whether the protective effect of ischaemic preconditioning (IPC) on endothelial function in coronary arteries of the rat involves prostaglandins. Methods: Isolated rat hearts perfused under constant flow conditions were exposed to 30 min of partial ischaemia (flow-rate 1 ml/min) followed by 20 min of reperfusion, after which coronaries were precontracted with U-46619 0.1 µM, and the coronary response to the endothelium-dependent vasodilator, serotonin (5-HT, 10 µM), was compared to that of the endothelium-independent vasodilator, sodium nitroprusside (SNP, 3 µM). Prostaglandin production was blocked with a perfusion of indomethacin 10 µM started 15 min before IPC or a corresponding sham period and stopped just before the 20-min reperfusion period. Results: In untreated hearts, ischaemia diminished selectively 5-HT-induced vasodilatation, compared to sham hearts. The vasodilatation by SNP was unaffected after ischaemia and reperfusion. IPC (5 min of zero-flow ischaemia followed by 10 min reperfusion before the 30-min partial ischaemia) preserved the vasodilatation produced by 5-HT. Enzymeimmunoassays showed an increased production of PGE2 in the IPC group. Treatment of hearts with indomethacin blocked the protective effect of IPC on the vasodilatation produced by 5-HT and decreased the production of PGE2. A 5-min perfusion with 3 nM PGE2 started 15 min before the partial ischaemia, protected the endothelium. This was blocked by 1 µM chelerythrine, but not by 0.3 µM glibenclamide. Conclusions: These results suggest that IPC affords protection to endothelial function in coronary arteries of the rat partially via the release of PGE2. Under our experimental conditions, the protective effect of PGE2 is mediated by PKC.

KEYWORDS Endothelial factors; Ischemia; Preconditioning; Prostaglandins; Reperfusion


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Cardiovasc ResHome page
M. A. Frias, S. Somers, C. Gerber-Wicht, L. H. Opie, S. Lecour, and U. Lang
The PGE2-Stat3 interaction in doxorubicin-induced myocardial apoptosis
Cardiovasc Res, October 1, 2008; 80(1): 69 - 77.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
D. L. Ngaage
Off-pump coronary artery bypass grafting: the myth, the logic and the science
Eur. J. Cardiothorac. Surg., October 1, 2003; 24(4): 557 - 570.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
K. Laude, P. Beauchamp, C. Thuillez, and V. Richard
Endothelial protective effects of preconditioning
Cardiovasc Res, August 15, 2002; 55(3): 466 - 473.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
P. Gres, R. Schulz, J. Jansen, C. Umschlag, and G. Heusch
Involvement of endogenous prostaglandins in ischemic preconditioning in pigs
Cardiovasc Res, August 15, 2002; 55(3): 626 - 632.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
A. Babsky, S. Hekmatyar, S. Wehrli, N. Doliba, M. Osbakken, and N. Bansal
Influence of Ischemic Preconditioning on Intracellular Sodium, pH, and Cellular Energy Status in Isolated Perfused Heart
Experimental Biology and Medicine, July 1, 2002; 227(7): 520 - 528.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
S. J. Sawyer, S. M. Norvell, S. M. Ponik, and F. M. Pavalko
Regulation of PGE2 and PGI2 release from human umbilical vein endothelial cells by actin cytoskeleton
Am J Physiol Cell Physiol, September 1, 2001; 281(3): C1038 - C1045.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.